By Christina Sibley Lic. Insurance Producer, Bachelor of Science Health Studies/Gerontology.

Now that Fall is behind us and visions of Spring are ahead, why are we still talking about Medicare enrollment? What many people don’t know is that there are many enrollment periods to Medicare and special circumstances around those periods.
Why is this important? There may be several reasons someone wishes to make a change outside of the October 15th – December 7th annual open enrollment period. Perhaps the options they currently have are just too expensive, or they need an option with different or more benefits. Maybe there have been life changes like a move, change in finances, change in other health insurance coverage, or newly diagnosed health problem.
Here are a few common additional enrollment periods, that may apply. These are not the entire list so if these don’t apply, or you aren’t sure, you can always ask your Medicare broker to see if you may qualify for one or visit Medicare.gov for more information.

January through March- Medicare Advantage Open Enrollment

· Those already on a Medicare Advantage (part C) plan can make one plan change to another Medicare Advantage plan or go to original Medicare and add a drug plan. The plan changes are usually effective the first day of the following month.
· It’s important to remember that this period can’t be used to go from original Medicare to a Medicare advantage plan or to change from a drug plan to another drug plan BUT There may be other special election periods that can be used for that.

January through September- Low Income Subsidy/Dual (Medicare/Medicaid) eligibility

· If you are currently qualified for Extra Help or Medicaid health coverage, become newly eligible, or lose your qualification for Extra Help or Medicaid you may make a change. Those currently qualified may make one change per quarter for the first three quarters of the year.
· Extra Help is a program that helps pay prescription drug premiums and/or prescription costs for those who meet the income and resources requirements. Even if your income is too high for food assistance or Medicaid, you may still qualify for Extra Help. One of the most beneficial aspects of Extra Help is it may keep qualified people out of the dreaded coverage gap or “donut hole” and can lower drug copays. Apply through Social Security or your Medicare broker may be willing to help you.
Special enrollment and special needs plans based on health conditions.

Special enrollment and special needs plans based on health conditions.
· Some areas of Oklahoma may have “special needs plans” based on chronic health conditions, such as heart disease or diabetes.
· Enrollment in these plans, if you qualify, is open through the year. Enrollment is based solely on existence of a qualifying health condition, not income. Other special needs plans, not based on health conditions, may be available and based on enrollment in both Medicare and Medicaid.

Special Election Period due to declared disaster

· If you missed an election period that you otherwise qualified for due to a declared disaster in your area (like one of our famous Oklahoma ice storms, floods, and/or tornados) there may be an additional election period granted for a specific amount of time. These usually apply to valid election periods for those new to Medicare or those already enrolled in Medicare.

Special Election period- you moved

· If you move out of state, a service area (usually based on counties), or there’s a new plan available to you because you moved, even if your plan is still available, you may make a change and do not have to wait until October 15th. This also applies if you recently moved back to the US, you moved into or out of an institution (like a skilled nursing or long-term care facility), or you were released from jail.
· Time to pick a new plan may be limited to just 2 months, so be sure to review your options and change right away.

You lost other insurance coverage or have the chance to get other insurance coverage such as:

· Employer coverage, Medicaid, Program for All Inclusive Care for the Elderly (PACE), or Other credible coverage (like VA or Tricare). Specific rules may apply. Not all other coverage is considered “credible”, especially if you wish to delay or stop part B enrollment. Make sure to do thorough research to avoid penalties for late enrollment or non-coverage.

These are just some examples of additional enrollment periods and special circumstances that may apply to you. The Medicare website is always the best source of information but feel free to reach out to your broker as well if you have questions or visit our Resource Guide at www.okveterannews.com – see Medicare Brokers.

Steven Howell, the Pharmacy Manager at INTEGRIS Baptist Medical Center, receives a token of appreciation from Alex Azar the former Secretary of the United States Department of Health and Human Services.
Howell was given this medallion for his role in discovering extra doses of the Pfizer vaccine. In early shipments of the vaccine, the FDA had originally approved the use of five doses per vial. But when examining the doses sent to INTEGRIS Health, Howell discovered that you could actually get six doses from each vial. He quickly informed his brother-in-law, U.S. Marine Colonel Gregory McCarthy, who happens to be on the White House Coronavirus Task Force. McCarthy relayed the information up the chain of command and after further review, the FDA granted permission for hospitals around the country to use the sixth dose. “In essence, we received 20-percent more doses than we originally thought,” said Howell. “We were able to vaccinate that many more people and none of the vaccine went to waste.”
Howell may downplay his involvement in this potentially life-saving discovery, but he fully understands the importance of expanding the use of such a scarce commodity. “It’s exciting to be a part of something so monumental,” admits Howell.
We applaud you, Steven, for your daily contributions to INTEGRIS Health and the citizens of Oklahoma, and we commend you for your service to the entire country.

About a year after COVID-19 arrived in the United States, vaccines and treatment innovations are providing light at the end of a long tunnel. OU Health has been a state and national leader in the rigorous research that has made such advances possible.
As an academic healthcare system, OU Health brings many resources to the battle against COVID-19, from laboratory research to clinical trials to public health tools like epidemiology and disease surveillance.
“None of the current vaccines or therapeutics would ever have come to fruition had it not been for scientists who understand the mechanisms of the disease or clinical trials that help us identify better ways to treat patients,” said Jennifer Holter-Chakrabarty, M.D., a hematologist-oncologist at OU Health Stephenson Cancer Center and a campus leader in COVID-19 research.
“This pandemic has served as an example of how quickly you can respond to something like COVID-19 when you already have a model where scientists and physicians are working together,” she added. “Because OU Health has researchers and clinicians across many specialties, we are able to contribute to the discoveries that are being made.”
OU Health is maintaining a biorepository of samples from patients who have been treated for COVID-19, allowing researchers to access those samples as they conduct studies, including one that is testing the ability of a sugar-based molecule to suppress inflammation caused by the virus. Patient samples are also used to study the length and quality of immunity in people who have had COVID-19, compared with immunity provided by the vaccine.
In addition, OU Health is participating in two national registries of COVID-19 patients that allow researchers and clinicians to study treatments and outcomes over time, so they can better understand the virus on a national scale.
“Because this is a new virus never before seen in humans, we have pooled our resources throughout the United States to collect data and find themes,” Holter-Chakrabarty said. “This is not uncommon in medicine. It allows us to identify how certain patient populations are experiencing the virus, in ways that we may not have observed within our individual healthcare institutions.”
A related effort is Stephenson Cancer Center’s participation in a National Cancer Institute clinical trial on the effects of COVID-19 in people being treated for cancer. Of the 793 national locations for the trial, Stephenson Cancer Center is the top enroller of patients.
“When you are diagnosed with cancer, that’s frightening enough, but when you are diagnosed with COVID-19 in addition, we want to help you continue your cancer therapy, treat you for COVID-19, and look at the impact of both of them in this patient population,” Holter-Chakrabarty said. “In this trial, we are collecting data for two years from patients with cancer who’ve had COVID-19. This will allow us to look for themes that emerge on a national scale and determine how we address them.”
Stephenson Cancer Center has initiated a related trial for its own patients undergoing treatment for cancer. Trial participants receive an app on their phones that prompts them regularly to answer questions about any symptoms of COVID-19 they may have. If the app’s algorithm determines they need to be tested for COVID-19, a test will be scheduled. Patients who test positive receive oxygen and pulse monitors that will help their healthcare providers determine if they can stay at home or if they need to be treated at the hospital.
Other studies involve monitoring patients with COVID-19 for thrombotic complications, particularly deep vein thrombosis, pulmonary embolism and stroke. “Because some of these conditions have been associated with COVID-19, our public health researchers are following incidence rates of patients getting a clot in their arm or leg, a clot that moves to their lungs, or having a stroke,” Holter-Chakrabarty said. “Looking at surveillance data from various hospitals will allow us to see if any particular patient populations are more susceptible to these complications.”
Drawing on its wide range of research expertise, OU Health is also conducting studies on topics as varied as improving sterilization techniques for personal protective equipment (PPE); using artificial intelligence and bioinformatics to predict where future COVID-19 outbreaks will occur; and assessing the effect of social isolation during the pandemic on the rate of child maltreatment cases.
In addition, OU Health researchers are participating in the development of potential future vaccines. Because of its longtime relationship with pharmaceutical company Novavax, including ongoing research for vaccines against the Respiratory Syncytial Virus and Ebola Virus, the OU Health Sciences Center is playing a role in the company’s newly developed vaccine for COVID-19.
“We established biomedical research laboratory models to study the vaccine’s ability to produce an immune response,” said virologist James Papin, Ph.D., who is leading the study for the OU Health Sciences Center. “We’re contributing to the data that allowed Novavax to successfully move into Phase 1 and Phase 2 clinical trials and, now, transition to Phase 3 trials. Hopefully, that vaccine will also receive Emergency Use Authorization from the Food and Drug Administration so that it can be added to current vaccination options, increasing the supply of vaccines and effectively increasing vaccination rates.”
OU Health’s researchers and clinicians are also championing the current vaccines on the market, as well as the importance of high vaccination rates in order to stem the rise of the pandemic. Both vaccines use Messenger RNA (mRNA) to prompt the body to build antibodies against COVID-19. Although the vaccines were developed in record-breaking time, the concept of mRNA has been well-studied and used for years in various treatments, including cancer.
“Some people are concerned about the fast track of the vaccines, but they were developed using platforms that have been studied for a long time,” Papin said. “That speaks to the importance of research – investigators had already done years of work showing that mRNA is safe and effective. That’s why the vaccines could be developed so quickly. But we also need to take what we’ve learned and stay diligent. Infectious diseases are one of the greatest threats to humankind. Hopefully, we will turn the corner soon on the current pandemic, but if it happens again, we will have the data and understanding to develop therapeutics even faster than we are doing today.”

VillagesOKC, an organization of virtual neighbors enabling mature adults to come together to learn, plan, and serve with spirit and dignity, has been selected by the Mather Institute as an honoree of the 2020 Promising Practices Awards. VillagesOKC was recognized for Bringing Brain Health Education to the Community.
Organizations working with older adults from across the country sent in submissions about how they are moving away from conventional practices through new and innovative approaches. Eight organizations with powerful ideas and practices were highlighted for continuing to move the aging services industry forward, despite an abnormally unusual year.
“The Promising Practices Awards honor true leaders in ideation and implementation,” said Cate O’Brien, PhD, assistant vice president and director of the Mather Institute. “We hope these projects will serve as a catalyst for organizations across the country and around the world to spark innovation in their own programs.”
Over the past two years, VillagesOKC has worked closely with MINDRAMP Consulting, a brain health consulting and coaching company, to develop and sustain a Brain Health Initiative, offering MINDRAMP’s unique approach through live presentations, videos, podcasts, web-based classes and workshops. The initiative presents a behavioral and risk-management approach that is specifically tailored for the mature adult population. From 2019-2020, more than 360 older adults attended brain health classes.
From Feb. to June 2021, VillagesOKC will again partner with MINDRAMP to host a weekly Brain Academy. The full semester of engaging, evidence-based sessions will be held via a secure Zoom meeting. The program is $100 for non-members and $50 for members of VillagesOKC. Programming includes:
Level 1. Strong Brains, Sharp Minds: The Art & Science of Aging Intentionally
* Feb. 10 – The Longevity Paradox & The Call to Adventure
* Feb. 24 – May the Force Be with You & Navigational Aids
Level 2. Mapping the Future of Your Mature Mind
* March 10 – Motivation & Assessments
* March 24 – Planning & Skills for Sustainability
Level 3. – Eight Behaviors That Shape Your Brain
* April 14 – Cogwheel Overview, Physical Exercise & Mental Stimulation
* April 28 – Social Engagement, Stress Management & Diet and Nutrition
* May 12 – Sleep, Medical Factors & Environmental Conditions
Practicum 1. Designing Your Brain Health Action Plan
* May 26 – Design Your Personal Action Plan
Practicum 2. Lions & Tigers & Bears: Group Coaching to Overcome Obstacles, Setbacks and Discouragement
* June 9 – Put Your Personal Action Plan into Action
* June 23 –Develop Strategies for Sustainability
“The Brain Health Initiative has expanded the range and depth of our remotely delivered services and has positioned us as a leader in the aging community,” said Marilyn Olson, executive director of VillagesOKC. “As MINDRAMP says, ‘Everyone wants a better brain.’ Offering this program has grown our membership and our place in the greater community.”
To learn more and to register for the Brain Academy, please email info@villagesokc.org or call 405.990.6637.

The American Health Care Association and National Center for Assisted Living (AHCA/NCAL), representing more than 14,000 nursing homes and assisted living communities across the country that provide care to approximately five million people each year, released the following statement regarding the pace of the COVID-19 vaccination rollout.
The following statement is attributable to Mark Parkinson, president and CEO of AHCA/NCAL:
“With record-breaking cases in nursing homes right now due to soaring community spread, no one could wish for a swifter delivery of the vaccine than those living and working in long term care facilities. While we must be efficient in order to save the lives of our most vulnerable, we must also be thoughtful and targeted in our approach.
“Since the creation of the pharmacy partnership program for long term care, we knew that this rollout would take time: to approve the vaccines for use; to have enough supply for each state to activate the program; to encourage states to prioritize our population; to distribute and ship the vaccine to the pharmacies; to prepare the clinics for our residents who have complex conditions; to gather consent among residents or their health care representatives; and to educate staff, residents and family members about the need to take the vaccine. The plan from the beginning was to vaccinate long term care residents and staff with the first dose over three to four weeks, beginning the last two weeks of December. Therefore, we are in the midst of the pharmacy partnership program really getting underway, and we believe this program is operating in accordance with its intended timeline.
“As of right now, we are not aware of widespread issues or delays with this vaccine rollout, and if there were, we would be among the first to sound the alarm. We continue to assist a minority of member providers who come to us looking for assistance or clarity, but the majority of providers tell us that their clinics have been scheduled or have already occurred and that overall, the program is running smoothly.
“As with any effort of this scale, there will be issues, and vaccine hesitancy is our primary focus at this moment. Uptake among residents and staff is varying widely, but in general, staff seem to be mirroring the general public’s reaction: excitement mixed with hesitation about the vaccines’ development and safety. We launched the #GetVaccinated campaign to encourage all long term care residents, families and staff members to consent to the vaccine as well as provide credible information to help inform their decision. We call on public health officials, social media companies, and members of the media to combat misinformation about the vaccine to aid in this effort.
“And pardon the pun, but we get more than one shot at this. We remain hopeful that uptake for the vaccine will improve as this pharmacy partnership program continues to unfold in the coming weeks and months in the subsequent clinics.
“This is a monumental effort to vaccinate millions of our nation’s vulnerable seniors and their caregivers, and we are confident and grateful that everyone involved is working as hard and as fast as they can while still ensuring we get this right.”

Story by Darl Devault, Feature Writer

COVID-19 patients without serious symptoms requiring hospitalization and high flow oxygen or mechanical ventilation may receive Eli Lilly’s bamlanivimab and Regeneron’s casirivimab / imdevimab COVID-19 infusion therapies at the Oklahoma COVID Care Center in Edmond. Patients should be infused within 10 days of onset of any symptoms.
The single intravenous (IV) infusion therapy is U.S. Food and Administration authorized for the treatment of mild to moderate coronavirus disease 2019 (COVID-19). The FDA Emergency Use Authorization (EUA) was issued to Regeneron Pharmaceuticals Inc. November. 21, 2020
A member of the American Association of Nurse Practitioners, Kara De La Pena, who owns an Edmond based urgent care mobile practice, is advising COVID-19 patients over the age of 65 to take advantage of this life-saving infusion. With 15 years of experience in healthcare and recently treating COVID-19 patients in the outpatient setting, De La Pena says “I have seen many people, including close family members, almost lose their life to this disease. These infusions, also termed “BAM” infusions, along with mass vaccinations for COVID-19, will hopefully end this pandemic.”
This infusion treatment is for mild to moderate COVID-19 positive testing adults and pediatric patients (12 years of age or older weighing at least 88 pounds) who are at high risk for progressing to severe COVID-19. This includes those who are 65 years of age or older or who have certain chronic medical conditions.
This is the same therapy first described in the media as a Regeneron cocktail when given to former President Donald Trump in early October under an emergency, single-person authorization. Infectious diseases expert Anthony Fauci, M.D., has said of Regeneron’s experimental antibody cocktail: “There is a reasonably good chance in fact it made (President Donald Trump) much better.”
These two therapies infuse monoclonal antibodies (mAbs) intended to directly neutralize the COVID-19 virus and prevent progression of the disease.
“The FDA Authorizes these monoclonal antibody therapies that may help outpatients avoid hospitalization and alleviate the burden on our health care system,” said FDA Commissioner Stephen M. Hahn, M.D. “As part of our Coronavirus Treatment Acceleration Program, the FDA uses every possible pathway to make new treatments available to patients as quickly as possible while continuing to study the safety and effectiveness of these treatments.”
High risk is defined as COVID-19 testing patients who meet at least one of the following criteria:
* Have a body mass index (BMI) over 35.
* Have chronic kidney disease.
* Have diabetes.
* Have immunosuppressive disease.
* Are currently receiving immunosuppressive treatment.
* Are over 65 years of age.
* Are over 55 years of age AND have:
* cardiovascular disease, OR * hypertension, OR * chronic obstructive pulmonary disorder/other chronic respiratory disease
* Are 12-17 years of age AND have: * BMI over 85th percentile for their age and gender based on CDC growth charts, OR * sickle cell disease, OR * congenital or acquired heart disease, OR * neurodevelopmental disorders, OR * medical-related technological dependence, OR * asthma, reactive airway, or other chronic respiratory disease that requires daily medication for control
For more info call 405-726-9859 to speak to an infusion coordinator or visit www.okcovidcare.com
The scheduling team coordinates convenient infusion appointment times.
Please note hydrating 2-3 days before a scheduled infusion appointment is encouraged to aid with the infusion treatment.
Patients begin their infusion day by completing a one-page health assessment so infusion nurses can identify current medications and recent health events. The nurses take patient vital signs and review overall health condition. Patients should make the infusion team aware of any recent surgery, scheduled surgery, or infections, as this could interfere with that day’s scheduled treatment.
Once all assessments and reviews are completed, the infusion nurse inserts a small IV needle into the hand or arm. Depending on the medication therapy selected for treatment, infusion times will vary from 30 minutes to six hours; however, most medications are administered in two hours or less.
Every patient is closely monitored from start to finish. Most patients feel normal after their infusion and can resume their daily activities, while others experience acute fatigue. The Oklahoma Covid Care Center strongly encourages patients to consider having transportation available to them.
In a clinical trial of patients with COVID-19, casirivimab and imdevimab, administered together, were shown to reduce COVID-19-related hospitalization or emergency room visits in patients at high risk for disease progression within 28 days after treatment when compared to placebo.
Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses. Casirivimab and imdevimab are monoclonal antibodies specifically directed against the spike protein of SARS-CoV-2, designed to block the virus’ attachment and entry into human cells.
“The emergency authorization of these monoclonal antibodies administered together offers health care providers another tool in combating the pandemic,” said Patrizia Cavazzoni, M.D., acting director of the FDA’s Center for Drug Evaluation and Research.
The issuance of an EUA is different than FDA approval. In determining whether to issue an EUA, the FDA evaluates the totality of available scientific evidence and carefully balances any known or potential risks with any known or potential benefits of the product for use during an emergency.
When used to treat COVID-19 for the authorized population, the known and potential benefits of these antibodies outweigh the known and potential risks. There are no adequate, approved and available alternative treatments for the authorized population.
“I get emotional thinking about these infusions. I am overjoyed we have a tool in helping prevent COVID-19 from replicating and causing more harm in the body. I wish we had this tool sooner to help save some of the 400,000 Americans we have lost already, 3,293 of those being Oklahomans,” De La Pena said.
As an advanced practice registered nurse her certifications in advanced cardiac life support, basic life support, and pediatric advanced life support allow her to fully evaluate her senior patient’s situations. She has been nursing COVID-19 outpatients since the beginning of the pandemic as the owner of NP 2 Go.
“Many people qualify for the infusion.” De La Pena said. “If they have questions, they may call the center to confirm their qualification. There is another infusion clinic at St. Mary’s Regional Hospital in Enid (patients just need a referral from their provider). Oklahoma ER and Hospital in Edmond expects to add the infusion services soon.”
Fact sheets about using casirivimab and imdevimab administered together in treating COVID-19 are available to patients. These fact sheets include dosing instructions, potential side effects and drug interactions. Possible side effects include anaphylaxis and infusion-related reactions, fever, chills, hives, itching and flushing.

By Nick Thomas

Raised in a rough Harlem neighborhood in the 40s and 50s, childhood proved challenging for Hank Garrett.
“We lived in the slums and I’d walk into the kitchen in the mornings to find the floor covered with roaches,” said Garrett from his home in California. “And I still remember waking up one day with a weight on my chest – it was a rat.”
As outlined in his 2020 autobiography, “From Harlem Hoodlum to Hollywood Heavyweight,” other hardships dogged young Hank throughout his troubled teen years.
“I saw fights, stabbings, and shootings – it was a daily situation,” recalled Garrett. But he endured, including a later near fatal car accident, eventually turning his life around to focus on physical fitness and becoming a professional wrestler before turning to acting.
During a brief time on the New York police force, Garratt auditioned for “Car 54, Where Are You?” a new television comedy series that debuted in 1961.
“When I told my commanding officer I had a chance to work on a television series, he looked at me and said, ‘tough decision isn’t it Hank – to become a television star or stay a cop in New York!” Garrett recalled. “‘Car 54’ opened up an acting career for me.”
Series creator Nat Hiken hired Garrett as Officer Ed Nicholson. “So I went from real cop to reel cop!” said Garrett.
The show also starred Fred (later ‘Herman Munster’) Gwynne and Joe E. Ross who were partners in the series.
“Fred was very soft-spoken and truly a gentleman who also wrote and illustrated children’s books,” he said. “He lost a child who drowned and we were shooting when the news came. We were all devastated and shared his pain.”
As for Ross, ‘what a character,” said Garrett with a laugh. “Joe would bring in ladies of the evening and at one point asked if one could be put on the payroll as his acting coach! The producers didn’t go for it. And, of course, he could never remember his lines and that’s why he always went ‘ooh! ooh!’ until the words came to him.”
Numerous other roles came Garrett’s way, often being cast as the bad guy opposite some of Hollywood’s biggest names including Kirk Douglas in “A Lovely Way to Die” (1968) where a stray punch from Douglas gave Garrett a bloody nose. But Hank got even with the A-lister crowd several years later in a memorably violent fight scene in “Three Days of the Condor” breaking Robert Redford’s nose.
Playing the ‘heavy,’ he says, wasn’t a stretch given his tough childhood. Nor did he forget his troubled past and has worked tirelessly for years with prisoners, veterans, and at-risk youth he calls Hankster’s Kids (see www.hankgarrett.biz).
“I hope people will be interested in my book because the proceeds will go to disabled vets and the kids.”
Nick Thomas teaches at Auburn University at Montgomery, Ala., and has written features, columns, and interviews for over 850 newspapers and magazines.

Photography and Text by Terry “Travels with Terry” Zinn t4z@aol.com

While you are taking advantage pf my previous months articles on Kansas, might as well move on to Kansas City.
Oscar Hammerstein in his lyrics in “ Oklahoma ” said Kansas City was up to date in a humorous way, but it’s even truer today, as Kansas City is updating its attractions with multi-million dollar investments. Culture and cuisine is always high on my travel itineraries and while I only saw a few of Kansas City standouts on this trip, there was still a lot to absorb in Kansas City , Mo. One example is the National World War I Museum at Liberty Memorial with its symbolic see-through bridge over a field of 9,000 poppies, which represents a thousand casualties for each poppy. The exhibits were both diverse and meaningful, and a ride to the top of the memorial with its rewarding panoramic view is worthwhile.
The Belger Arts Center/Red Star Studios is an example of a partnership of industry and a passion in art collecting. Besides its display of contemporary art from the personal collection of businessman and wife, John and Maxine Belger, it is also home to a number of rotating solo exhibitions as well as touring group artists. The converted warehouse at 2100 Walnut St. , offers loft-like exhibition space for a number of large scale art. Dr. Kathleen Desmond of REVIEW magazine said, “The Belger Arts Center is amazing in its presence in Kansas City ; not quite a museum, not a university gallery, not a commercial gallery. It is an entity in itself that defies definition. It is an incredible resource and contribution to the visual arts in Kansas City .”
Another outstanding contribution is the Kemper Museum of Contemporary Art where the building itself, built in 1994 is a work of art. It’s airy and up lifting design, lightens the spirit and is a complement to the upbeat contemporary art it contains. With a new exhibition almost every month it’s easy to see why this is a Kansas City favorite, as is the outstanding museum’s Café Sebastienne. I had a delightful lunch surrounded by a variety of paintings reminiscent of famous artists. My dining companion/painting was a coy girl in a Mary Cassatt style. Relaxing in the café setting or in the light filled and enclosed courtyard is as much a treat as is the contemporary cuisine.
The Nelson-Atkins Museum of Art brings together masterful examples from many periods and world cultures. The American Indian gallery, which opened in November of 2009 is extensive – I’m told is one of the largest exhibits devoted to Native Americans. When I visited, there was a collection of Rodin bronzes, with an outstanding impact on this viewer. The museum’s addition of the Bloch building, houses several contemporary collections and illuminates at night. There are several galleries I did not get a chance to see, and there are many concerts and special events held throughout each season.
For upscale dining the menu and service at Pierponts, lived up to its reputation as a “culinary jewel.” Named after railroad baron, J. P. Morgan, Pierpont’s is located appropriately enough in Union Station where other attractions also reside. But don’t let that put you off, as Pierpont’s interior is as elegant and yet friendly as can be. No wonder it was named by the local press “ Best Place to Entertain an out-of-town Guest.” Their prime steaks and seafood along with their wine list, is a must to enjoy.
The Kansas City Ballet has a relatively new permanent home, the Todd Bolender Center for Dance & Creativity, a top notch renovation of an old energy generating factory. Semblances of its history can hardly be seen amid the state of the art rehearsal halls and pragmatic architecture. Unique to this home of ballet is the rehearsal hall where studio productions are held, with seated viewing above the dance floor. Just watching a class of these artistic athletes is inspiring. Also inspiring is the new Kauffman Center for the Performing Arts with its two theatres, and expansive lobbies. An expansive view of downtown Kansas City is available for prime viewing from the lobby at intermission with the innovative slanted panorama glass walls. I vow I will experience a performance there, on my next visit.
I did however sample a delightful menu at the nearby Webster House, where I was also tempted by their antique and modern home décor shop. But the star of this visit was the fried green tomatoes with tomato jam ~ inventive and flavor packed. Webster House, a historic renovated school house, is within walking distance to the Kauffman Center and thus is perfect for pre-theatre dining.
And let’s not forget your home base for a restful retreat from all that Kansas City offers, and that would be the Crowne Plaza Kansas City located amid all the action downtown. Comfortable, convenient and affordable, what more could you want except room service and they have that too! Everything is up to date in Kansas City.
For more information and upcoming schedules:
www.belgerartscenter.org
www.kemperart.org
www.nelson-atkins.org
www.pierponts.com
www.kauffmancenter.org
www.websterhousekc.com
www.crowneplaza.com

Mr. Terry Zinn – Travel Editor
Past President: International Food Wine and Travel Writers Association
3110 N.W. 15 Street – Oklahoma City, OK 73107
https://realtraveladventures.com/?s=terry+zinn
https://realtraveladventures.com/?s=zinn
http://new.okveterannews.com/?s=TERRY+ZINN
www.martinitravels.com

The National Committee for Quality Assurance (NCQA) recently announced that five INTEGRIS Family Care Clinics in Enid have earned Patient-Centered Medical Home (PCMH) Recognition renewal.
The clinics received the initial recognition for using evidence-based, patient-centered processes that focus on highly coordinated care and long-term, participative relationships. The facilities receiving the PCMH Certificate of Recognition renewal are listed below:
INTEGRIS Family First
INTEGRIS Christopher A. Shearer, D.O.
INTEGRIS Dustin Baylor, M.D.
INTEGRIS N.W. Family Medicine Clinic
INTEGRIS Family Care Services of Enid
The NCQA Patient-Centered Medical Home is a model of primary care that combines teamwork and information technology to improve care, improve patients’ experience of care and reduce costs. Medical homes foster ongoing partnerships between patients and their personal clinicians, instead of approaching care as the sum of episodic office visits. Each patient’s care is overseen by clinician-led care teams that coordinate treatment across the health care system. Research shows that medical homes can lead to higher quality and lower costs and can improve patient and provider reported experiences of care.

Experience an unforgettable Valentine date with the Zoo’s socially distant, 21+ event dinner

Your valentine will go wild when you surprise them with a unique dinner experience at the Oklahoma City Zoo and Botanical Garden. The OKC Zoo is hosting two socially distant Valentine’s Dinner events at the Zoo’s Sea Lion Stadium on Saturday, February 13 and Sunday, February 14. Each event will be limited to 122 guests, 21 and older, to ensure adequate social distancing among attendees. Doors open at 6:30 p.m. and the first course is served at 7 p.m.
Participants will enjoy dining under the stars at private, socially distanced tables, arranged throughout the Zoo’s covered Sea Lion Stadium. Heat lamps will be aglow, creating a cozy setting but dress warmly. Each event will feature a three-course dinner provided by Salt and Surrey Catering. Menu options include a strawberry or tossed salad, south of France chicken, grilled pork loin with peach chutney, or portabella mushroom stack and a sweet ending with strawberry or chocolate mousse for dessert. Dinners will feature a full bar with domestic beer, wine, mixed drinks, soda and the event’s specialty cocktail, the Love Potion, available for purchase.
These one-of-kind dinners conclude with a splash as the Zoo’s California sea lions and harbor seals along with their talented caretakers entertain guests with specially-themed presentation, Sealed with a Fish!
“We are excited to expand our adult, 21 and older events and provide Zoo fans with a new, exclusive opportunity to celebrate the Valentine’s holiday in a memorable setting with our beloved wildlife,” said Jenna Dodson, OKC Zoo’s manager of events.
Turn up the romance and complement your lovely dinner with a half-dozen chocolate covered strawberries for an additional $35. Planning to propose this Valentine’s Day? We can help. Purchase a proposal package to present during the Valentine’s Dinner and a Zoo representative will reach out to help you plan the special occasion. For more information, contact events@okczoo.org.
Valentine’s Dinner admission is $120 per couple for ZOOfriends members and $140 per couple for nonmembers. During the ticket purchasing process, you will be asked to give your menu choices and a place to request special seating with friends and other couples! Tickets are now available at okczoo.org. Tickets are non-refundable and non-transferable and events will be held rain or shine.
Cupid gives his “seal” of approval with the OKC Zoo’s Valentine’s Dinner! Get your tickets now. The Oklahoma City Zoo is open Thursday through Monday from 9 a.m. to 5 p.m. with no public access on Tuesdays and Wednesdays. Advance tickets are required for all guests and ZOOfriends members and can be purchased at www.okczoo.org/tickets. Zoo tickets are limited each day to maintain social distancing among guests. Located at the crossroads of I-44 and I-35, the OKC Zoo is a proud member of the Association of Zoos and Aquariums, the American Alliance of Museums, Oklahoma City’s Adventure District and an Adventure Road partner. Regular admission is $12 for adults and $9 for children ages 3-11 and seniors ages 65 and over. Children two and under are admitted free.
Stay connected with the Zoo on Facebook, Twitter, Instagram and TikTok, and by visiting our blog stories. Zoo fans can support the OKC Zoo by becoming a ZOOfriends member. Starting at $45, memberships can be purchased at ZOOfriends.org and provide access to the OKC Zoo for an entire year plus, additional benefits and discounts. To learn more about Zoo happenings, call (405) 424-3344 or visit okczoo.org.